Direct-to-consumer personal car insurance provider Esurance has selected Elinor MacKinnon as its new managing director and chief information officer. In his new role, MacKinnon will spearhead all of Esurance's information technology, ...
Tags: car insurance, Esurance, managing director, insurance
The Anti-Infective Drugs Advisory Committee (AIDAC) to the US Food and Drug Administration (FDA) has recommended the use of Novartis's tobramycin inhalation powder (TIP) to treat cystic fibrosis (CF) patients whose lungs contain bacteria ...
Novartis has commenced shipment of Fluvirin influenza vaccine for the 2012-2013 influenza season, in the US. Novartis plans to ship more than 30 million doses of the Fluvirin vaccine which has been reformulated to include two new ...
Tags: Novartis, fluvirin influenza seasonal vaccine, seasonal influenza
US-based Cornerstone Therapeutics has entered into an agreement to acquire the US marketing rights to Chiesi Farmaceutici's BETHKIS (Tobramycin Inhalation Solution), designed for the treatment of cystic fibrosis patients with Pseudomonas ...
Tags: US-based Cornerstone Therapeutics, Chiesi Farmaceutici's BETHKIS
Validus Pharmaceuticals and Wood Creek Capital Management have acquired the US rights to six product lines from Novartis Pharmaceuticals Corporation (NPC). The acquired six product lines include Lopressor (metoprolol tartrate USP) ...
Indian pharmaceutical company Cipla has named Subhanu Saxena as its new chief executive officer, effective 1 February 2013. Saxena worked with various companies including Citicorp, The Boston Consulting Group, PepsiCo and most recently ...
Tags: Cipla, pharmaceutical company
Agri-business giant Syngenta has put multi-sourced IT at the heart of its ambitious plan to double its revenues in the next eight years. It has moved from having thousands of suppliers across the world to a selected few who it has close ...
Tags: Syngenta, Multi-Sourcing, telephony systems
Novartis has won FDA approval for Afinitor (everolimus) tablets for the treatment of postmenopausal women with advanced hormone receptor-positive, HER2-negative breast cancer (advanced HR+ breast cancer) in combination with exemestane after ...
The US Food and Drug Administration (FDA) has approved Novartis Afinitor (everolimus) to treat patients with non-cancerous kidney tumors associated with tuberous sclerosis complex (TSC). The approval was based on the Phase III ...